541 related articles for article (PubMed ID: 37494786)
1. Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine.
Jin S; Zhang L; Wang L
Biomed Pharmacother; 2023 Sep; 165():115215. PubMed ID: 37494786
[TBL] [Abstract][Full Text] [Related]
2. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
Rahul ; Siddique YH
CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis.
Dunkel P; Chai CL; Sperlágh B; Huleatt PB; Mátyus P
Expert Opin Investig Drugs; 2012 Sep; 21(9):1267-308. PubMed ID: 22741814
[TBL] [Abstract][Full Text] [Related]
5. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases.
Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479
[TBL] [Abstract][Full Text] [Related]
6. Molecular Targets Underlying the Neuroprotective Effects of Boswellic Acid: A Systematic Review.
Khaafi F; Javadi B
Mini Rev Med Chem; 2023; 23(19):1912-1925. PubMed ID: 36998129
[TBL] [Abstract][Full Text] [Related]
7. Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms.
Haddadi R; Shahidi Z; Eyvari-Brooshghalan S
Phytomedicine; 2020 Dec; 79():153320. PubMed ID: 32920285
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNAs: New Insights in Neurodegenerative Diseases.
Anilkumar AK; Vij P; Lopez S; Leslie SM; Doxtater K; Khan MM; Yallapu MM; Chauhan SC; Maestre GE; Tripathi MK
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396946
[TBL] [Abstract][Full Text] [Related]
9. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
Tan L; Yu JT; Tan L
J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Nrf2 signaling pathway using phytochemical ingredients: A novel therapeutic road map to combat neurodegenerative diseases.
Bai X; Bian Z; Zhang M
Phytomedicine; 2023 Jan; 109():154582. PubMed ID: 36610130
[TBL] [Abstract][Full Text] [Related]
11. Flavonoid-based therapies in the early management of neurodegenerative diseases.
Solanki I; Parihar P; Mansuri ML; Parihar MS
Adv Nutr; 2015 Jan; 6(1):64-72. PubMed ID: 25593144
[TBL] [Abstract][Full Text] [Related]
12. The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids.
Kooshki L; Zarneshan SN; Fakhri S; Moradi SZ; Echeverria J
Phytomedicine; 2023 Apr; 112():154686. PubMed ID: 36804755
[TBL] [Abstract][Full Text] [Related]
13. Curcuminoids in neurodegenerative diseases.
Kim DS; Kim JY; Han Y
Recent Pat CNS Drug Discov; 2012 Dec; 7(3):184-204. PubMed ID: 22742420
[TBL] [Abstract][Full Text] [Related]
14. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
Ruffini N; Klingenberg S; Schweiger S; Gerber S
Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
[TBL] [Abstract][Full Text] [Related]
15. Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review.
Bansal R; Singh R
Med Res Rev; 2018 Jul; 38(4):1126-1158. PubMed ID: 28697282
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders.
Gupta R; Advani D; Yadav D; Ambasta RK; Kumar P
Mol Neurobiol; 2023 Nov; 60(11):6476-6529. PubMed ID: 37458987
[TBL] [Abstract][Full Text] [Related]
17. Current Small Molecule-Based Medicinal Chemistry Approaches for Neurodegeneration Therapeutics.
Sanghai N; Vuong B; Burak Berk A; Afridi MSK; Tranmer GK
ChemMedChem; 2024 May; 19(9):e202300705. PubMed ID: 38329887
[TBL] [Abstract][Full Text] [Related]
18. Natural Compounds Preventing Neurodegenerative Diseases Through Autophagic Activation.
Huang Z; Adachi H
J UOEH; 2016 Jun; 38(2):139-48. PubMed ID: 27302727
[TBL] [Abstract][Full Text] [Related]
19. The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases.
Maher P
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234550
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review.
Velayudhan L; Van Diepen E; Marudkar M; Hands O; Suribhatla S; Prettyman R; Murray J; Baillon S; Bhattacharyya S
Curr Pharm Des; 2014; 20(13):2218-30. PubMed ID: 23829360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
